Award
Delivery Order #SPE2DR26FLTP0
Delivery Order for Entyvio 300 mg Vials to Support Healthcare
Buyer
Defense Logistics Agency
Award Amount
$74,493.75
Ceiling
$74,493.75
Awarded
February 13, 2026
Period of Performance
Feb 13, 2026 – Feb 17, 2026
Identifier
SPE2DR26FLTP0
NAICS
325411
This award represents a delivery order contract issued under an existing multi-year indefinite delivery vehicle (IDV) held by DMS Pharmaceutical Group Inc., a company specializing in pharmaceutical and healthcare supplies. The contract procures Entyvio 300 mg vials, a specific pharmaceutical product, for use in supporting medical treatment needs. The delivery order is notable for ensuring timely access to critical medication within the contracted timeframe. The scope of work includes providing a defined quantity of these pharmaceutical vials to be delivered during a short performance window, maintaining continuity in the healthcare supply chain. This contract was awarded competitively under the umbrella of the IDV, which was itself awarded through a competitive process to guarantee a steady, reliable source of essential pharmaceutical products. The delivery order was awarded recently with a focused, short-term delivery schedule, aligning with the multi-year framework of the parent contract. The parent IDV contract underscores the importance of DMS Pharmaceutical Group's role in supporting public health initiatives by providing vital medications over an extended period until the end of 2036.
Description
4570827489!ENTYVIO 300 MG VIALS